1
Garo Khanarian
Jeffrey Lawrence Daecher, Steven David Fields, Garo Khanarian, Alan Daniel Stein: Process and apparatus for forming plastic sheet. Rohm and Haas Company, S Matthew Cairns, Darryl P Frickey, John L Lemanowicz, February 6, 2001: US06183829 (40 worldwide citation)

Disclosed is an apparatus for formation of high quality plastic sheet in a continuous fashion. Also disclosed are a variety of optical and electronic display applications for high quality plastic sheet produced in a continuous fashion.


2
George Stuart Cockerill, Malcolm Clive Carter, Stephen Barry Guntrip, Kathryn Jane Smith: Fused heterocyclic compounds as protein tyrosine kinase inhibitors. SmithKline Beecham Corporation, John L Lemanowicz, May 21, 2002: US06391874 (79 worldwide citation)

Substituted heteroaromatic compounds of formula (I) and in particular substituted quinolines and quinazolines, are protein tyrosine kinase inhibitors. The compounds are described as are methods for their preparation, pharmaceutical compositions including such compounds and their use in medicine, for ...


3

4

5
Richard Roy Clikeman, Morris Christopher Wills, Peter Reeves Sperry, Martin Vogel, Jiun Chen Wu, Willie Lau: Method for forming pluralities of droplets and polymer particles having low polydispersity. Rohm and Haas Company, S Matthew Cairns, Darryl P Frickey, John L Lemanowicz, November 2, 1999: US05976405 (52 worldwide citation)

Disclosed are uniformly sized domains of liquid crystals, a method for forming the domains, and their performance in polymer dispersed liquid crystal displays. The method provides the ability to form discrete domains of liquid crystal surrounded by a polymer shell, also known as polymer encased liqu ...


6
Richard Roy Clikeman, Morris Christopher Wills, Peter Reeves Sperry, Martin Vogel, Jiun Chen Wu, Willie Lau: Droplets and particles containing liquid crystal and films and apparatus containing the same. Rohm and Haas Company, John L Lemanowicz, Darryl P Frickey, November 10, 1998: US05835174 (52 worldwide citation)

Disclosed are uniformly sized domains of liquid crystals, a method for forming the domains, and their performance in polymer dispersed liquid crystal displays. The method provides the ability to form discrete domains of liquid crystal surrounded by a polymer shell, also known as polymer encased liqu ...


7

8
George Stuart Cockerill, Malcolm Clive Carter, Stephen Barry Guntrip, Kathryn Jane Smith: Protein tyrosine kinase inhibitors. SmithKline Beecham Corporation, John L Lemanowicz, April 20, 2004: US06723726 (43 worldwide citation)

Substituted heteroaromatic compounds, and in particular substituted bicyclic heteroaromatic compounds of formula (I), wherein X is N or CH; A represents a fused 5, 6 or 7-membered heterocyclic ring containing 1 to 5 heteroatoms which may be the same or different and which are selected from N, O or S ...


9
George Stuart Cockerill, Malcolm Clive Carter, Stephen Barry Guntrip, Kathryn Jane Smith: Heterocyclic compounds. SmithKline Beecham Corporation, John L Lemanowicz, December 7, 2004: US06828320 (40 worldwide citation)

Substituted heteroaromatic compounds, and in particular substituted quinolines and quinazolines, are protein tyrosine kinase inhibitors. The compounds are described as are methods for their preparation, pharmaceutical compositions including such compounds and their use in medicine, for example in th ...


10
Stephen Thomas Davis, Scott Howard Dickerson, Philip Anthony Harris, Robert Neil Hunter III, Lee Frederick Kuyper, Karen Elizabeth Lackey, Michael Joseph Luzzio, James Marvin Veal, Duncan Herrick Walker: Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors. SmithKline Beecham Corporation, John L Lemanowicz, April 9, 2002: US06369086 (39 worldwide citation)

The present invention relates generally to novel substituted oxindole compounds and compositions. Such compounds and compositions have utility as pharmacological agents in treating diseases or conditions alleviated by the inhibition or antagonism of protein kinase activated signalling pathways. In p ...



Click the thumbnails below to visualize the patent trend.